CD1D and metastatic melanoma: In addition, glycosphingolipids, such as the ganglioside GD3, have been demonstrated to contribute substantially to the immunogenicity of metastatic melanoma and are presented to NKT cells through CD1d by DCs, coordinating antitumor responses (15–19).